Barclays Raises Biogen Forecasts After Physician Survey

By: via Benzinga
Barclays on Wednesday issued a report highlighting Biogen Inc (NASDAQ: BIIB) after they conducted a global multiple sclerosis (MS) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.